Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Arhaus Reports Surprising Quarterly Earnings Beat

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
DrugRetailers Trading online
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Arhaus (NASDAQ: ARHS) surprised investors with their latest quarterly report on March 7, 2024. The company announced adjusted earnings of $0.22 per share, beating the analyst consensus by 37.5%. This is a slight decrease of 35.29% from the previous year’s earnings of $0.34 per share.

In addition, Arhaus reported quarterly sales of $344.01 million, surpassing the analyst estimate by 2.83%. However, this represents a 3.46% decrease from sales in the same period last year, totaling $356.33 million.

Investors are eagerly awaiting the upcoming financial results for Arhaus, with analysts predicting a decline in both revenue and adjusted earnings for the quarter.

ARHS Stock Shows Signs of Recovery with Pre-Market Rise

On March 7, 2024, ARHS stock exhibited mixed performances as it traded near the top of its 52-week range and above its 200-day simple moving average. According to data from CNN Money, the price of ARHS shares experienced a slight decrease of $0.11 since the market last closed, representing a 0.85% drop from its previous closing price of $12.82.

Despite this slight decline, ARHS stock showed signs of potential recovery as it rose by $0.18 in pre-market trading. This upward movement in the pre-market session could indicate a shift in investor sentiment towards the stock, potentially leading to a positive trading day ahead.

ARHS Stock Analysis: Strong Growth in Revenue and Net Income, Mixed Performance in Third Quarter

On March 7, 2024, ARHS stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was reported at $1.23 billion, which represents a significant increase of 54.21% compared to the previous year. Additionally, the total revenue for the third quarter of the fiscal year stood at $326.23 million, showing a 4.26% increase from the previous quarter.

In terms of net income, ARHS reported a net income of $136.63 million for the past year, reflecting a substantial growth of 547.03% compared to the previous year. However, the net income for the third quarter was reported at $19.74 million, indicating a decrease of 50.87% from the previous quarter.

Earnings per share (EPS) also showed a mixed performance for ARHS stock. The EPS for the past year was reported at $0.98, representing a significant increase of 534.7% compared to the previous year. However, the EPS for the third quarter was reported at $0.14, showing a decrease of 50.92% from the previous quarter.

Overall, ARHS stock demonstrated strong growth in total revenue and net income over the past year, indicating positive financial performance. However, the decrease in net income and EPS for the third quarter may have raised concerns among investors. It is important for investors to closely monitor the company’s financial performance and future outlook to make informed investment decisions.

Tags: ARHS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Retail Stock Bull Market

Arhaus Projects Strong Financial Performance for 2024

CRWD stock news

Entegris NASDAQ ENTG Receives Buy Recommendation and 150 Price Target from Needham Analyst

Retail Stock Bull Market

BJs Wholesale Club Exceeds Earnings Expectations in Q1 2024

Recommended

Dare Bioscience Stock

Dare Bioscience Stock: Analysts Project Triple-Digit Upside Potential

4 months ago
Bloom Energy Stock

Fuel Cell Leader Bloom Energy Capitalizes on AI Infrastructure Demand

3 months ago
AI travel

NextTrip Inc Announces Official Transition and Ticker Symbol Change

2 years ago
Genprex Stock

Genprex Shares Plunge Amid Heavy Selling Pressure

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

Trending

Camping World Stock
Consumer & Luxury

Camping World’s New Leadership Faces First Major Test

by Jackson Burston
February 7, 2026
0

All eyes are on Camping World Holdings as it approaches a pivotal quarterly report. This will be...

Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Camping World’s New Leadership Faces First Major Test
  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com